These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo]. Hu LD; Tang X; Cui FD Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775 [TBL] [Abstract][Full Text] [Related]
23. Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations. Souto EB; Wissing SA; Barbosa CM; Müller RH J Cosmet Sci; 2004; 55(5):463-71. PubMed ID: 15608996 [TBL] [Abstract][Full Text] [Related]
24. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Fang JY; Fang CL; Liu CH; Su YH Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447 [TBL] [Abstract][Full Text] [Related]
25. Stability of lipid excipients in solid lipid nanoparticles. Radomska-Soukharev A Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589 [TBL] [Abstract][Full Text] [Related]
26. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405 [TBL] [Abstract][Full Text] [Related]
27. Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams. Souto EB; Müller RH Pharmazie; 2007 Jul; 62(7):505-9. PubMed ID: 17718190 [TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of Shirasu Porous Glass (SPG) membrane emulsification for the preparation of colloidal lipid drug carrier dispersions. Joseph S; Bunjes H Eur J Pharm Biopharm; 2014 May; 87(1):178-86. PubMed ID: 24333666 [TBL] [Abstract][Full Text] [Related]
30. [Preparation and characterization of solid lipid nanoparticles of norcantharidin]. Tian HY; Zhai GX Zhong Yao Cai; 2007 Sep; 30(9):1146-8. PubMed ID: 18236763 [TBL] [Abstract][Full Text] [Related]
31. Solid lipid nanoparticles as drug delivery systems. Manjunath K; Reddy JS; Venkateswarlu V Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465 [TBL] [Abstract][Full Text] [Related]
32. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. Venkateswarlu V; Manjunath K J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472 [TBL] [Abstract][Full Text] [Related]
34. Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenization. Li YC; Dong L; Jia A; Chang XM; Xue H Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):541-4. PubMed ID: 16762843 [TBL] [Abstract][Full Text] [Related]
35. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method]. Yang Y; Feng JF; Zhang H; Luo JY Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):650-3. PubMed ID: 16830822 [TBL] [Abstract][Full Text] [Related]
36. Influence of membrane structure on the preparation of colloidal lipid dispersions by premix membrane emulsification. Joseph S; Bunjes H Int J Pharm; 2013 Mar; 446(1-2):59-62. PubMed ID: 23410990 [TBL] [Abstract][Full Text] [Related]
37. [Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release]. Chen YJ; Jin RX; Zhou YQ; Zeng J; Zhang H; Feng QR Zhongguo Zhong Yao Za Zhi; 2006 Mar; 31(5):376-9. PubMed ID: 16711418 [TBL] [Abstract][Full Text] [Related]
38. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636 [TBL] [Abstract][Full Text] [Related]
39. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Pardeike J; Hommoss A; Müller RH Int J Pharm; 2009 Jan; 366(1-2):170-84. PubMed ID: 18992314 [TBL] [Abstract][Full Text] [Related]
40. Solid lipid nanoparticles (SLN) for topical drug delivery: incorporation of the lipophilic drugs N,N-diethyl-m-toluamide and vitamin K. Işcan Y; Wissing SA; Hekimoğlu S; Müller RH Pharmazie; 2005 Dec; 60(12):905-9. PubMed ID: 16398266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]